• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于尿液伏安法电子舌测量的新型膀胱癌非侵入性监测方法。

New bladder cancer non-invasive surveillance method based on voltammetric electronic tongue measurement of urine.

作者信息

Monreal-Trigo Javier, Alcañiz Miguel, Martínez-Bisbal M Carmen, Loras Alba, Pascual Lluís, Ruiz-Cerdá José Luis, Ferrer Alberto, Martínez-Máñez Ramón

机构信息

Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat Politècnica de València - Universitat de València, Camino de Vera, s/n, 46022 Valencia, Spain.

CIBER de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, Madrid, Spain.

出版信息

iScience. 2022 Aug 4;25(9):104829. doi: 10.1016/j.isci.2022.104829. eCollection 2022 Sep 16.

DOI:10.1016/j.isci.2022.104829
PMID:36034216
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9399275/
Abstract

Bladder cancer (BC) is the sixth leading cause of death by cancer. Depending on the invasiveness of tumors, patients with BC will undergo surgery and surveillance lifelong, owing the high rate of recurrence and progression. In this context, the development of strategies to support non-invasive BC diagnosis is focusing attention. Voltammetric electronic tongue (VET) has been demonstrated to be of use in the analysis of biofluids. Here, we present the implementation of a VET to study 207 urines to discriminate BC and non-BC for diagnosis and surveillance to detect recurrences. Special attention has been paid to the experimental setup to improve reproducibility in the measurements. PLSDA analysis together with variable selection provided a model with high sensitivity, specificity, and area under the ROC curve AUC (0.844, 0.882, and 0.917, respectively). These results pave the way for the development of non-invasive low-cost and easy-to-use strategies to support BC diagnosis and follow-up.

摘要

膀胱癌(BC)是癌症导致死亡的第六大主要原因。根据肿瘤的侵袭性,膀胱癌患者将终身接受手术和监测,因为其复发和进展率很高。在这种情况下,支持非侵入性膀胱癌诊断策略的开发正受到关注。伏安电子舌(VET)已被证明可用于生物流体分析。在此,我们展示了一种伏安电子舌用于研究207份尿液样本,以鉴别膀胱癌和非膀胱癌,用于诊断和监测复发情况。我们特别关注实验设置,以提高测量的重现性。偏最小二乘判别分析(PLSDA)结合变量选择提供了一个具有高灵敏度、特异性和ROC曲线下面积(AUC)的模型(分别为0.844、0.882和0.917)。这些结果为开发支持膀胱癌诊断和随访的非侵入性低成本且易于使用的策略铺平了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c4/9399275/629d5b5289fe/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c4/9399275/f17f76d36356/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c4/9399275/6fafa2db201d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c4/9399275/e3f8b65079fc/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c4/9399275/dbbf2803638b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c4/9399275/abb9a7659a20/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c4/9399275/c6972212088d/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c4/9399275/629d5b5289fe/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c4/9399275/f17f76d36356/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c4/9399275/6fafa2db201d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c4/9399275/e3f8b65079fc/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c4/9399275/dbbf2803638b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c4/9399275/abb9a7659a20/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c4/9399275/c6972212088d/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c4/9399275/629d5b5289fe/gr6.jpg

相似文献

1
New bladder cancer non-invasive surveillance method based on voltammetric electronic tongue measurement of urine.基于尿液伏安法电子舌测量的新型膀胱癌非侵入性监测方法。
iScience. 2022 Aug 4;25(9):104829. doi: 10.1016/j.isci.2022.104829. eCollection 2022 Sep 16.
2
Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer.基于 mRNA 的尿液检测在膀胱癌患者监测中的前瞻性验证。
Eur Urol. 2019 May;75(5):853-860. doi: 10.1016/j.eururo.2018.11.055. Epub 2018 Dec 12.
3
MALBAC-based chromosomal imbalance analysis: a novel technique enabling effective non-invasive diagnosis and monitoring of bladder cancer.基于 MALBAC 的染色体不平衡分析:一种新型技术,可有效实现膀胱癌的非侵入性诊断和监测。
BMC Cancer. 2018 Jun 15;18(1):659. doi: 10.1186/s12885-018-4571-7.
4
Fibroblast growth factor receptor 3 mutation analysis on voided urine for surveillance of patients with low-grade non-muscle-invasive bladder cancer.尿脱落细胞中成纤维细胞生长因子受体 3 突变分析在低级别非肌肉浸润性膀胱癌患者监测中的应用。
Clin Cancer Res. 2010 Jun 1;16(11):3011-8. doi: 10.1158/1078-0432.CCR-09-3013. Epub 2010 Apr 19.
5
Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillance.一种用于膀胱癌监测的新型基于mRNA的尿液检测方法准确性提高。
BJU Int. 2018 Jan;121(1):29-37. doi: 10.1111/bju.14019. Epub 2017 Oct 12.
6
Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study.一项全面多中心研究中用于非肌层浸润性膀胱癌患者复发监测的新型、灵敏且特异的尿液检测方法的验证
Front Genet. 2019 Dec 18;10:1237. doi: 10.3389/fgene.2019.01237. eCollection 2019.
7
Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up.男性膀胱癌患者诊断及随访期间尿脱落细胞中多种突变的检测
Oncotarget. 2016 Oct 11;7(41):67435-67448. doi: 10.18632/oncotarget.11883.
8
A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine.用于检测尿脱落细胞中非肌层浸润性膀胱癌(NMIBC)复发的甲基化检测。
BJU Int. 2012 Mar;109(6):941-8. doi: 10.1111/j.1464-410X.2011.10428.x. Epub 2011 Jul 14.
9
Ability of a urine gene expression classifier to reduce the number of follow-up cystoscopies in bladder cancer patients.尿液基因表达分类器降低膀胱癌患者随访膀胱镜检查次数的能力。
Transl Res. 2019 Jun;208:73-84. doi: 10.1016/j.trsl.2019.02.003. Epub 2019 Feb 7.
10
Xpert bladder cancer monitor in surveillance of bladder cancer: Systematic review and meta-analysis.Xpert膀胱癌监测仪在膀胱癌监测中的应用:系统评价与荟萃分析。
Urol Oncol. 2022 Apr;40(4):163.e1-163.e9. doi: 10.1016/j.urolonc.2021.08.017. Epub 2021 Sep 14.

引用本文的文献

1
Relevance of rs920778 and rs12826786 Genetic Variants in Bladder Cancer Risk and Survival.rs920778和rs12826786基因变异与膀胱癌风险及生存的相关性
Cancers (Basel). 2024 Jan 19;16(2):434. doi: 10.3390/cancers16020434.

本文引用的文献

1
Electronic tongue applications for wastewater and soil analysis.电子舌在废水和土壤分析中的应用。
iScience. 2022 Apr 29;25(5):104304. doi: 10.1016/j.isci.2022.104304. eCollection 2022 May 20.
2
Using machine learning and an electronic tongue for discriminating saliva samples from oral cavity cancer patients and healthy individuals.使用机器学习和电子舌区分口腔癌患者和健康个体的唾液样本。
Talanta. 2022 Jun 1;243:123327. doi: 10.1016/j.talanta.2022.123327. Epub 2022 Feb 22.
3
Developing non-invasive bladder cancer screening methodology through potentiometric multisensor urine analysis.
通过电势多传感器尿液分析开发无创膀胱癌筛查方法。
Talanta. 2021 Nov 1;234:122696. doi: 10.1016/j.talanta.2021.122696. Epub 2021 Jul 8.
4
Evaluating the potential use of electronic tongue in early identification and diagnosis of bacterial infections.评估电子舌在细菌感染早期识别和诊断中的潜在应用。
Infect Drug Resist. 2019 Aug 7;12:2445-2451. doi: 10.2147/IDR.S213938. eCollection 2019.
5
Critical review of electronic nose and tongue instruments prospects in pharmaceutical analysis.电子鼻和舌仪器在药物分析中的应用前景的批判性评价。
Anal Chim Acta. 2019 Oct 24;1077:14-29. doi: 10.1016/j.aca.2019.05.024. Epub 2019 May 15.
6
Urinary Metabolic Signatures Detect Recurrences in Non-Muscle Invasive Bladder Cancer.尿液代谢特征可检测非肌肉浸润性膀胱癌的复发情况。
Cancers (Basel). 2019 Jun 29;11(7):914. doi: 10.3390/cancers11070914.
7
Integrative Metabolomic and Transcriptomic Analysis for the Study of Bladder Cancer.整合代谢组学和转录组学分析用于膀胱癌研究
Cancers (Basel). 2019 May 16;11(5):686. doi: 10.3390/cancers11050686.
8
Hope and challenge: Precision medicine in bladder cancer.希望与挑战:膀胱癌的精准医学。
Cancer Med. 2019 Apr;8(4):1806-1816. doi: 10.1002/cam4.1979. Epub 2019 Mar 24.
9
Discovering biomarkers in bladder cancer by metabolomics.通过代谢组学发现膀胱癌的生物标志物。
Biomark Med. 2018 Dec;12(12):1347-1359. doi: 10.2217/bmm-2018-0229. Epub 2018 Dec 3.
10
Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring.膀胱癌液体活检生物标志物:患者诊断和监测的当前需求。
Int J Mol Sci. 2018 Aug 24;19(9):2514. doi: 10.3390/ijms19092514.